MedTrace Logo

Neurobiology of Alcohol and Nicotine Co-Addiction

NCT03338933 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 109

Last updated 2025-02-13

Study results available
· View outcomes & findings →

Summary

This proposal addresses the critical absence of information about the neurobiology of recovery from Alcohol Use Disorder (AUD) in alcohol and nicotine users.

Conditions

Interventions

BEHAVIORAL

magnetic resonance imaging (MRI)

All subjects will undergo a baseline MRI and subjects in both alcohol groups (alcohol use disorder and combined alcohol and nicotine use disorder) will undergo a followup MRI 3 months after baseline.

Sponsors & Collaborators

  • Oregon Health and Science University

    collaborator OTHER

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • William F Hoffman, MD PhD · VA Portland Health Care System, Portland, OR

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-08
Primary Completion
2023-01-03
Completion
2023-01-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03338933 on ClinicalTrials.gov